Enliven Therapeutics, Inc. (ELVN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 463.14M | 474.88M | 482.68M | 495.62M | 294.32M | 318.13M | 297M | 318.13M | 337.2M | 266.15M | 268.61M | 283.18M | 298M | 77.75M | 88.23M | 64.26M | 78.53M | 110.67M | 106M | 71.36M |
| Cash & Short-Term Investments | 452.4M | 462.62M | 477.56M | 490.5M | 289.56M | 313.44M | 291.83M | 312.39M | 320.5M | 253.15M | 263.48M | 277.87M | 292.1M | 75.54M | 86.16M | 60.34M | 72.9M | 110.02M | 102.84M | 66.77M |
| Cash Only | 132.18M | 98.9M | 101.73M | 119.44M | 101.7M | 124.12M | 100.62M | 96.87M | 149.16M | 100.14M | 73.85M | 125.72M | 292.1M | 75.54M | 86.16M | 30.43M | 36.48M | 110.02M | 75.3M | 48.04M |
| Short-Term Investments | 320.22M | 363.73M | 375.83M | 371.07M | 187.85M | 189.32M | 191.21M | 215.52M | 171.34M | 153.01M | 189.63M | 152.15M | 0 | 0 | 0 | 29.91M | 36.42M | 0 | 27.54M | 18.73M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 10.74M | 12.26M | 5.12M | 0 | 4.76M | 4.69M | 54K | 5.74M | 10.05M | 10.05M | 0 | 0 | 5.9M | 2.22M | 0 | 3.92M | 5.63M | 0 | 3.16M | 4.59M |
| Total Non-Current Assets | 1.72M | 1.29M | 8.19M | 8.27M | 8.25M | 7.63M | 8.43M | 8.92M | 5.58M | 5.72M | 5.43M | 5.33M | 4.86M | 5.54M | 2.57M | 410K | 3.07M | 2.66M | 1.03M | 1.11M |
| Property, Plant & Equipment | 310K | 417K | 874K | 1.03M | 1.05M | 458K | 630K | 791K | 924K | 1.06M | 1.2M | 1.34M | 1.4M | 1.52M | 1.55M | 235K | 2.9M | 954K | 855K | 936K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54K | 54K | 0 | 175K | 175K | 0 | 175K | 175K |
| Other Non-Current Assets | 1.41M | 873K | 7.32M | 7.24M | 7.2M | 7.17M | 7.8M | 8.13M | 4.65M | 4.65M | 4.23M | 3.98M | 3.4M | 3.98M | 1.01M | 0 | 0 | 1.71M | 0 | 0 |
| Total Assets | 464.85M | 476.17M | 490.88M | 503.89M | 302.57M | 325.76M | 305.43M | 327.04M | 342.78M | 271.87M | 274.04M | 288.5M | 302.87M | 83.3M | 90.8M | 64.67M | 81.6M | 113.33M | 107.03M | 72.47M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 53.63% | 46.17% | 60.72% | 54.07% | -11.73% | 19.82% | 11.45% | 13.36% | 13.18% | 226.38% | 201.82% | 346.14% | 271.15% | -26.5% | -15.17% | -10.77% | -0.1% | 24.75% | 6.84% | -34.9% |
| Total Current Liabilities | 11.49M | 16.57M | 14.65M | 15.21M | 13.97M | 15.91M | 17.03M | 22.11M | 25.03M | 25.89M | 12.08M | 9.15M | 10.94M | 9.71M | 8.33M | 3.3M | 7.22M | 5.75M | 7.19M | 6.97M |
| Accounts Payable | 1.64M | 2.16M | 1.43M | 2.35M | 1.56M | 1.34M | 1.02M | 1.08M | 2.73M | 532K | 1.49M | 2.84M | 5.86M | 3.44M | 2.99M | 1.14M | 1.88M | 2.52M | 2.48M | 2.63M |
| Days Payables Outstanding | 12.21K | 3.59K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.78K | 10.24K |
| Short-Term Debt | 302K | 399K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 445K | 508K | 0 | 250K | 254K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.51M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 9.54M | 14.01M | 4.04M | 63K | 2.16M | 4.81M | 216K | 11.57M | 10.45M | 10.36M | 368K | 692K | 3.72M | 320K | 1.08M | 1.05M | 3.7M | 233K | 2.9M | 3M |
| Current Ratio | 40.32x | 28.66x | 32.95x | 32.58x | 21.06x | 19.99x | 17.44x | 14.39x | 13.47x | 10.28x | 22.24x | 30.96x | 27.23x | 8.00x | 10.59x | 19.46x | 10.87x | 19.24x | 14.75x | 10.23x |
| Quick Ratio | 40.32x | 28.66x | 32.95x | 32.58x | 21.06x | 19.99x | 17.44x | 14.39x | 13.47x | 10.28x | 22.24x | 30.96x | 27.23x | 8.00x | 10.59x | 19.46x | 10.87x | 19.24x | 14.75x | 10.23x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 108K | 103K | 204K | 302K | 0 | 0 | 6K | 34K | 67K | 214K | 360K | 508K | 150.41M | 810K | 1.58M | 1.97M | 714K | 466K | 528K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 204K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.97M | 0 | 466K | 528K |
| Deferred Tax Liabilities | 0 | 108K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 103K | 0 | 302K | 0 | 0 | 6K | 34K | 67K | 214K | 360K | 508K | 150.41M | 810K | 1.58M | 0 | 714K | 0 | 0 |
| Total Liabilities | 11.49M | 16.68M | 14.75M | 15.41M | 14.27M | 15.91M | 17.03M | 22.11M | 25.07M | 25.96M | 12.29M | 9.51M | 11.45M | 160.12M | 9.14M | 3.3M | 9.19M | 6.47M | 7.65M | 7.5M |
| Total Debt | 302K | 399K | 387K | 580K | 365K | 0 | 85K | 169K | 252K | 335K | 332K | 329K | 326K | 323K | 320K | 445K | 2.48M | 159K | 716K | 782K |
| Net Debt | -131.88M | -98.5M | -101.34M | -118.86M | -101.34M | -124.12M | -100.54M | -96.7M | -148.91M | -99.81M | -73.52M | -125.39M | -291.78M | -75.21M | -85.84M | -29.99M | -34.01M | -109.86M | -74.58M | -47.26M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | 0.00x | 0.01x | 0.03x | 0.00x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 453.37M | 459.6M | 476.12M | 488.47M | 288.3M | 309.85M | 288.4M | 304.93M | 317.71M | 245.91M | 261.75M | 278.99M | 291.42M | -76.83M | 81.65M | 61.36M | 72.41M | 106.86M | 99.37M | 64.97M |
| Equity Growth % | 57.26% | 48.33% | 65.09% | 60.19% | -9.26% | 26% | 10.18% | 9.3% | 9.02% | 420.09% | 220.57% | 354.65% | 302.44% | -171.89% | -17.83% | -5.55% | -4.21% | 26.56% | 4.94% | -38.88% |
| Book Value per Share | 7.22 | 8.11 | 7.67 | 9.37 | 5.76 | 6.21 | 5.98 | 6.34 | 7.56 | 5.98 | 6.38 | 6.81 | 15.74 | -11.69 | 12.42 | 9.34 | 11.02 | 16.26 | 15.96 | 14.67 |
| Total Shareholders' Equity | 453.37M | 459.6M | 476.12M | 488.47M | 288.3M | 309.85M | 288.4M | 304.93M | 317.71M | 245.91M | 261.75M | 278.99M | 291.42M | -76.83M | 81.65M | 61.36M | 72.41M | 106.86M | 99.37M | 64.97M |
| Common Stock | 61K | 59K | 59K | 59K | 49K | 49K | 47K | 47K | 47K | 41K | 41K | 41K | 41K | 1K | 1K | 27K | 27K | 1K | 27K | 19K |
| Retained Earnings | -370.79M | -347.17M | -317.5M | -297.35M | -272.02M | -243.47M | -220.29M | -197.14M | -177.19M | -154.45M | -135.08M | -114.31M | -97.59M | -82.86M | -73.31M | -173.59M | -162.14M | -45.2M | -133.18M | -119.53M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -382K | 334K | 221K | -177K | -16K | 55K | 242K | -139K | -53K | 141K | -147K | -111K | 0 | -149.75K | 0 | -35K | -51K | 0 | -2K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |